Preview

Научно-практическая ревматология

Расширенный поиск

Современный взгляд на проблему кахексии и саркопении при ревматоидном артрите

https://doi.org/10.14412/1995-4484-2012-1116

Список литературы

1. <div><p>Roubenoff R., Heymsfield S.B., Kehayias J.J. et al. Standardization of nomenclature of body composition in weight loss. Am J Clin Nutr 1997;66(1):192-6.</p><p>Kotler D.P. Cachexia. Ann Intern Med 2000;133(8):622-34.</p><p>Cahill G.F, Jr. Starvation in man. N Engl J Med 1970;282(12):668-75.</p><p>Delmonico M.J., Harris T.B., Lee J.S. et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 2007;55(5):769-74.</p><p>Goodpaster B.H., Park S,W., Harris T.B. et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 2006;61(10):1059-64.</p><p>Paget J. Nervous mimicry organic diseases. Lancet 1873;2:727-9.</p><p>Gabriel S.E. The epidemiology of rheumatoid аrthritis. Rheum Dis Clin North Am 2001;27(2):269-81</p><p>Symmons D.P. Mortality in rheumatoid аrthritis. Br J Rheumatol 1988;27(Suppl. 1):44-54.</p><p>Wolfe F., Mitchell D.M., Sibley J.T. et al. The mortality of rheumatoid arthritis. Arthr Rheum 1994;37(4):481 -94</p><p>Gabriel S.E., Crowson C.S., Kremers H.M. et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthr Rheum 2003;48(1):54-8.</p><p>Roubenoff R., Roubenoff R.A., Ward L.M. et al. Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol 1992;19(10):1505-10.</p><p>Engvall I.L., Elkan A.C., Tengstrand B. et al. Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin-like growth factor. Scand J Rheumatol 2008;37(5):321-8.</p><p>Roubenoff R. Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21stv century. Arthr Res Ther 2009;11(2):108.</p><p>Roubenoff R., Rall L.C. Humoral mediation of changing body composition during aging and chronic inflammation. Nutr Rev 1993;51(1):1-11.</p><p>Morley J.E., Thomas D.R., Wilson M.M. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 2006;83(4):735-43.</p><p>Arshad A., Rashid R., Benjamin K. The effect of disease activity on fat-free mass and resting energy expenditure in patients with rheumatoid arthritis versus noninflammatory arthropathies/soft tissue rheumatism. Mod Rheumatol 2007;17(6):470-5.</p><p>Munro R., Capell H. Prevalence of low body mass in rheumatoid arthritis: association with the acute phase response. Ann Rheum Dis 1997;56(5):326-9.</p><p>Hernandez-Beriain J.A., Segura-Garcia C., Rodriguez-Lozano B. et al. Undernutrition in rheumatoid arthritis patients with disability. Scand J Rheumatol 1996;25(6):383-7.</p><p>Elkan A.C., Hakansson N., Frostegard J. et al. Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study. Arthr Res Ther 2009;11(2):R37.</p><p>Elkan A.C., Engvall I.L., Cederholm T., Hafstrom I. Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, Mini Nutritional Assessment and body composition techniques. Eur J Nutr 2009;48(5):315-22.</p><p>Morgan S.L., Anderson A.M., Hood S.M. et al. Nutrient intake patterns, body mass index, and vitamin levels in patients with rheumatoid arthritis. Arthr Care Res 1997;10(1):9-17.</p><p>Escalante A., Haas R.W., del Rincon I. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med 2005;165(14):1624-9.</p><p>Westhoff G., Rau R., Zink A. Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index. Arthr Rheum 2007;56(11):3575-82.</p><p>Metsios G.S., Stavropoulos-Kalinoglou A., Panoulas V.F. et al. Rheumatoid cachexia and cardiovascular disease. Clin Exp Rheumatol 2009;27(6):985-8.</p><p>Wang Z., St-Onge M.P., Lecumberri B. et al. Body cell mass: model development and validation at the cellular level of body composition. Am J Physiol Endocrinol Metab 2004;286(1):123-8.</p><p>Roubenoff R., Roubenoff R.A., Cannon J.G. et al. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 1994;93(6):2379-86.</p><p>Clowes G.H. Jr, George B.C., Villee C.A. Jr, Saravis C.A. Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N Engl J Med 1983;308(10):545-52.</p><p>Rall L.C., Rosen C.J., Dolnikowski G. et al. Protein metabolism in rheumatoid arthritis and aging. Effects of muscle strength training and tumor necrosis factor alpha. Arthr Rheum 1996;39(7):1115-24.</p><p>Moldawer L.L., Rogy M.A., Lowry S.F. The role of cytokines in cancer cachexia. J Parenter Enteral Nutr 1992; 16(6 Suppl.):43S-49S.</p><p>Tocco-Bradley R., Georgieff M., Jones C.T. et al. Changes in energy expenditure and fat metabolism in rats infused with interleukin-1. Eur J Clin Invest 1987;17(6):504-10.</p><p>Hellerstein M.K., Meydani S.N., Meydani M. et al. Interleukin-1-induced anorexia in the rat. Influence of prostaglandins. J Clin Invest 1989;84(1):228-35.</p><p>Hoshino E., Pichard C., Greenwood C.E. et al. Body composition and metabolic rate in rat during a continuous infusion of cachectin. Am J Physiol 1991;260(1 Pt 1):27-36.</p><p>Warren R.S., Starnes H.F. Jr, Gabrilove J.L. et al. The acute metabolic effects of tumor necrosis factor administration in humans. Arch Surg 1987;122(12):1396-400.</p><p>Seaton T.B., Coombe N., Mittelman A. Tumor necrosis factor and hypermetabolism. Ann Intern Med 1990;112(9):715-6.</p><p>Guttridge D.C., Mayo M.W., Madrid L.V. et al. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 2000;289(5488):2363-6.</p><p>Walsmith J.M., Vannier E., Yarasheski K.E. et al. Patients with rheumatoid arthritis (RA) have low protein synthesis rates and elevated tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta 1 (TGF-beta) transcript levels in skeletal muscle. Arthr Rheum 2003;48:104.</p><p>Walsmith J.M., Lundgren N.T., Snydman L. et al. A high ratio of interleukin-1 beta(IL-1)to interleukin-1-receptor antagonist (IL-1RA) is associated with less sleep and higher physical activity in rheumatoid arthritis: a doubly labeled water (DLW) study. FASEB J 2002;16:A26.</p><p>Marcora S.M., Chester K.R., Mittal G. et al. Randomized phase</p><p>trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. Am J Clin Nutr 2006;84(6):1463-72.</p><p>Walsmith J., Abad L., Kehayias J., Roubenoff R. Tumor necrosis factor-alpha production is associated with less body cell mass in women with rheumatoid arthritis. J Rheumatol 2004;31(1):23-9.</p><p>Haren M.T., Kim M.J., Tariq S.H. et al. Andropause: a quality-of-life issue in older males. Med Clin North Am 2006;90(5):1005-23.</p><p>Tengstrand B., Carlstrom K., Hafstrom I. Gonadal hormones in men with rheumatoid arthritis from onset through 2 years. J Rheumatol 2009;36(5):887-92.</p><p>Straub R.H., Harle P., Atzeni F. et al. Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapy. J Rheumatol 2005;32(7):1253-8.</p><p>Dessein P.H., Joffe B.I., Stanwix A. et al. The acute phase response does not fully predict the presence of insulin resistance and dyslipidemia in inflammatory arthritis. J Rheumatol 2002;29(3):462-6.</p><p>Svenson K.L., Pollare T., Lithell H., Hallgren R. Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance. Metabolism 1988;37(2):125-30.</p><p>Dessein P.H., Joffe B.I., Stanwix A.E. Inflammation, insulin resistance, and aberrant lipid metabolism as cardiovascular risk factors in rheumatoid arthritis. J Rheumatol 2003;30:1403-5.</p><p>Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-а: direct role in obesity-linked insulin resistance. Science 1993;259:87-91.</p><p>Rask-Madsen C., Dominguez H., Ihlemann N. et al. Tumor necrosis factor-а inhibits insulin’s stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans. Circulation 2003;108:1815-21.</p><p>Larsen C.M., Faulenbach M., Vaag A. et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007;356:1517-26.</p><p>Popa C., Netea M.G., van Riel P.L. The role of TNFа in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res 2007;48:751-62.</p><p>Kiortsis D.N., Mavridis A.K., Vasakos S. et al. Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis 2005;64:765-6.</p><p>Huvers F.C., Popa C., Netea M.G. et al. Improved insulin sensitivity by anti-TNFа antibody treatment in patients with rheumatic diseases. Ann Rheum Dis 2007;66:558-9.</p><p>Di Rocco P., Manco M., Rosa G. et al. Lowered tumor necrosis factor receptors, but not increased insulin sensitivity, with infliximab. Obes Res 2004;12:734-9.</p><p>Lemmey A., Maddison P., Breslin A. et al. Association between insulin-like growth factor status and physical activity levels in rheumatoid arthritis. J Rheumatol 2001;28(1):29-34.</p><p>Rall L.C., Walsmith J.M., Snydman L. et al. Cachexia in rheumatoid arthritis is not explained by decreased growth hormone secretion. Arthr Rheum 2002;46(10):2574-7.</p><p>Rall L.C., Roubenoff R. Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. Rheumatology (Oxford) 2004;43(10):1219-23.</p><p>Roubenoff R., Walsmith J., Lundgren N. et al. Low physical activity reduces total energy expenditure in women with rheumatoid arthritis: implications for dietary intake recommendations. Am J Clin Nutr 2002;76(4):774-9.</p><p>Metsios G.S., Stavropoulos-Kalinoglou A., Koutedakis Y., Kitas G.D. Rheumatoid cachexia: causes, significance and possible interventions. Hosp Chronicles 2006;1:20-6.</p><p>Mancuso C.A., Rincon M., Sayles W., Paget S.A. Comparison of energy expenditure from lifestyle physical activities between patients with rheumatoid arthritis and healthy controls. Arthr Rheum 2007;57(4):672-8.</p><p>Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M. et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39(4):412-23.</p><p>Roubenoff R. Sarcopenia: effects on body composition and function. J Gerontol A Biol Sci Med Sci 2003;58(11):1012-7.</p><p>Roubenoff R., Castaneda C. Sarcopenia-understanding the dynamics of aging muscle. JAMA 2001;286(10):1230-1.</p><p>McArdle W.D., Katch F.I., Katch V.L. Body composition assessment. Exercise physiology, 4th ed. Baltimore: Williams and Wilkins, 1996:541-75.</p><p>Fleming A., Crown J.M., Corbett M. Prognostic value of early features in rheumatoid disease. Br Med J 1976;1(6020):1243-5.</p><p>Kaufmann J., Kielstein V., Kilian S. et al. Relation between body mass index and radiological progression in patients with rheumatoid arthritis. J Rheumatol 2003;30(11):2350-5.</p><p>Kremers H.M., Nicola P.J., Crowson C.S. et al. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthr Rheum 2004;50(11):3450-7.</p><p>Davies P.S.W. Anthropometry and body composition. In: Ulijaszek S.J., Mascie-Taylor C.G.N. et al. Anthropometry: the individual and the population. Cambridge: Cambridge University press, 1994:130-40.</p><p>Lee R.C., Wang Z., Heo M. et al. Total-body skeletal muscle mass: development and cross-validation of anthropometric prediction models. Am J Clin Nutr 2000;72(3):796-803.</p><p>Lee R.D., Neiman D.C. Anthropometry. Nutritional assessment, 4th ed. Boston: McGraw Hill, 2007;169-221.</p><p>Ellis K.J. Human body composition: in vivo methods. Physiol Rev 2000;80(2):649-80.</p><p>Lee S.J., Janssen I., Heymsfield S.B., Ross R. Relation between whole-body and regional measures of human skeletal muscle. Am J Clin Nutr 2004;80(5):1215-21.</p><p>Mitsiopoulos N., Baumgartner R.N., Heymsfield S.B. et al. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 1998;85(1):115-22.</p><p>Ross R. Magnetic resonance imaging provides new insights into the characterization of adipose and lean tissue distribution. Can J Physiol Pharmacol 1996;74(6):778-85.</p><p>Kyle U.G., Genton L., Hans D. et al. Age-related differences in fat-free mass, skeletal muscle, body cell mass and fat mass between 18 and 94 years. Eur J Clin Nutr 2001;55(8):663-72.</p><p>Pichard C., Kyle U.G. Body composition measurements during wasting diseases. Curr Opin Clin Nutr Metab Care 1998;1(4):357-61.</p><p>Lee R., Wang Z.-M., Heymsfield S.B. et al. Skeletal muscle mass: regional and whole body measurement methods. London: GMM, 2000;427-38.</p><p>Ferretti J.L., Cointry G.R., Capozza R.F. et al. Dual-energy X-ray absorbptiometry. In: Preedy V.R., Peters T.J. et al. Skeletal mass. London: GMM, 2002;453-8.</p><p>Slosman D.O., Casez J.P., Pichard C. et al. Assessment of whole-body composition with dual-energy X-ray absorptiometry. Radiology 1992;185(2):593-8.</p><p>Summers G.D., Deighton C.M., Rennie M.J., Booth A.H. Rheumatoid cachexia: a clinical perspective. Rheumatology (Oxford) 2008;47(8):1124-31.</p><p>Moore F.D., Olesen K.H., McMurray J.D. et al. The body cell mass and its supporting environment. Philadelphia: Saunders, 1963.</p><p>De Jong Z., Munneke M., Zwinderman A.H. et al. Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trial. Arthr Rheum 2003;48(9):2415-24.</p><p>De Jong Z., Munneke M., Zwinderman A.H. et al. Long term high intensity exercise and damage of small joints in rheumatoid arthritis. Ann Rheum Dis 2004;63(11):1399-405.</p><p>De Jong Z., Vliet Vlieland T.P. Safety of exercise in patients with rheumatoid arthritis. Curr Opin Rheumatol 2005;17(2):177-82.</p><p>Rall L.C., Meydani S.N., Kehayias J. et al. The effect of progressive resistance training in rheumatoid arthritis. Increased strength without changes in energy balance or body composition. Arthr Rheum 1996;39(3):415-26.</p><p>Edmonds S., Turnbull C., Blake D. Effect of intensive exercise on patients with active RA. Ann Rheum Dis 2001;60(4):429.</p><p>Hakkinen A., Sokka T., Kotaniemi A., Hannonen P. A randomized two-year study of the effects of dynamic strength training on muscle strength, disease activity, functional capacity, and bone mineral density in early rheumatoid arthritis. Arthr Rheum 2001;44(3):515-22</p><p>Ha kkinen A., Sokka T., Kautiainen H. et al. Sustained maintenance of exercise induced muscle strength gains and normal bone mineral density in patients with early rheumatoid arthritis: a 5 year follow up. Ann Rheum Dis 2004;63(8):910-6.</p><p>Ha kkinen A. Effectiveness and safety of strength training in rheumatoid arthritis. Curr Opin Rheumatol 2004;16(2):132-7.</p><p>Ha kkinen A., Ha kkinen K., Hannonen P. Effects of strength training on neuromuscular function and disease activity in patients with recent-onset inflammatory arthritis. Scand J Rheumatol 1994;23(5):237-42.</p><p>Ha kkinen A., Sokka T., Kotaniemi A. et al. Dynamic strength training in patients with early rheumatoid arthritis increases muscle strength but not bone mineral density. J Rheumatol 1999;26(6):1257-63.</p><p>Munneke M., de Jong Z., Zwinderman A.H. et al. Effect of a high-intensity weight-bearing exercise program on radiologic damage progression of the large joints in subgroups of patients with rheumatoid arthritis. Arthr Rheum 2005;53(3):410-7.</p><p>Ha kkinen A., Hannonen P., Nyman K. et al. Effects of concurrent strength and endurance training in women with early or longstanding rheumatoid arthritis: comparison with healthy subjects. Arthr Rheum 2003;49(6):789-97.</p><p>Marcora S.M., Lemmey A.B., Maddison PJ. Can progressive resistance training reverse cachexia in patients with rheumatoid arthritis? Results of a pilot study. J Rheumatol 2005;32(6):1031-9.</p><p>Ha kkinen A., Pakarinen A., Hannonen P. et al. Effects of prolonged combined strength and endurance training on physical fitness, body composition and serum hormones in women with rheumatoid arthritis and in healthy controls. Clin Exp Rheumatol 2005;23(4):505-12.</p><p>Rennie K.L., Hughes J., Lang R., Jebb S.A. Nutritional management of rheumatoid arthritis: a review of the evidence. J Hum Nutr Diet 2003;16(2):97-109.</p><p>Marcora S., Lemmey A., Maddison P. Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial. Clin Nutr 2005;24(3):442-54.</p></div><br />


Рецензия

Для цитирования:


Аникин С.Г., Торопцова Н.В. Современный взгляд на проблему кахексии и саркопении при ревматоидном артрите. Научно-практическая ревматология. 2012;50(4):73-79. https://doi.org/10.14412/1995-4484-2012-1116

For citation:


Anikin S.G., Toroptsova N.V. Current view of the problem of cachexia and sarcopenia in rheumatoid arthritis. Rheumatology Science and Practice. 2012;50(4):73-79. (In Russ.) https://doi.org/10.14412/1995-4484-2012-1116

Просмотров: 778


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)